Abstract
SETD7 is a lysine N-methyltransferase that targets many proteins important in breast cancer (BC). However, its role and clinical significance remain unclear. Here, we used online tools and multiple public datasets to explore the predictive potential of SETD7 expression (high or low quartile) considering BC subtype, grade, stage, and therapy. We also investigated overrepresented biological processes associated with its expression using TCGA-BRCA data. SETD7 expression was highest in the Her2 (ERBB2)-enriched molecular subtype and lowest in the basal-like subtype. For the basal-like subtype specifically, higher SETD7 was consistently correlated with worse recurrence-free survival (p < 0.009). High SETD7-expressing tumours further exhibited a higher rate of ERBB2 mutation (20% vs. 5%) along with a poorer response to anti-Her2 therapy. Overall, high SETD7-expressing tumours showed higher stromal and lower immune scores. This was specifically related to higher counts of cancer-associated fibroblasts and endothelial cells, but lower B and T cell signatures, especially in the luminal A subtype. Genes significantly associated with SETD7 expression were accordingly overrepresented in immune response processes, with distinct subtype characteristics. We conclude that the prognostic value of SETD7 depends on the BC subtype and that SETD7 may be further explored as a potential treatment-predictive marker for immune checkpoint inhibitors.
Funder
iBiMED research unit
MEDISIS
Comissão de Coordenação e Desenvolvimento Regional do Centro
Portuguese Science and Technology Foundation—FCT
Swedish Cancer Society
Karolinska Institute PhD
Region Stockholm
Reference110 articles.
1. Biological Processes and Signal Transduction Pathways Regulated by the Protein Methyltransferase SETD7 and Their Significance in Cancer;Batista;Signal Transduct. Target. Ther.,2018
2. Regulation of Estrogen Receptor Alpha by the SET7 Lysine Methyltransferase;Subramanian;Mol. Cell,2008
3. SETD7 Is a Prognosis Predicting Factor of Breast Cancer and Regulates Redox Homeostasis;Huang;Oncotarget,2017
4. Monteiro, F.L., Williams, C., and Helguero, L.A. (2022). A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer. Cancers, 14.
5. SET7/9 Promotes Hepatocellular Carcinoma Progression through Regulation of E2F1;Gu;Oncol. Rep.,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献